Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | SMYD3 | Q9H7B4 | 14/20 | 0.35 |
| ▸ | HRH2 | P25021 | 2/20 | 0.34 |
| ▸ | HRH1 | P35367 | 2/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.33 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8379153 | 1.00 | ROCK2 (0.35) | ROCK2SMYD3HRH2HRH1HRH3 | |
| SCHEMBL8882608 | 0.90 | DPP4 (0.36) | KCNQ3KCNQ2DPP4 | |
| SCHEMBL8690728 | 0.81 | CPN1 (0.38) | ROCK2KCNQ3KCNQ2DPP4 | |
| SCHEMBL8690804 | 0.80 | SMYD3 (0.38) | ROCK2SMYD3HRH2HRH1DPP4 | |
| SCHEMBL8383078 | 0.78 | OPRD1 (0.49) | SMYD3HRH2HRH1DPP4 | |
| SCHEMBL8716139 | 0.73 | SMYD3 (0.34) | SMYD3 | |
| SCHEMBL8379156 | 0.73 | ITGB3 (0.42) | SMYD3HRH2HRH1HRH3DPP4 | |
| SCHEMBL15045201 | 0.73 | DPP4 (0.49) | ROCK2SMYD3HRH3DPP4 | |
| SCHEMBL8690808 | 0.70 | MEN1 (0.40) | ROCK2SMYD3DPP4 | |
| SCHEMBL6435636 | 0.70 | ITGB3 (0.55) | SMYD3HRH2HRH1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5747522-A | ANTICOAGULANTS; ANTIINFLAMMATORY AGENTS; ANTITUMOR AGENTS | HOFFMAN-LA ROCHE INC. (US) | 1998-05-05 | — | — | US | disclosed |
| US-5670515-A | TREATMENT OF THROMBOSIS, STROKE, CARDIAC INFARCT, INFLAMMATION, AND ARTERIOSCLEROSIS; ANTITUMOR AGENTS, WOUND HEALING AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1997-09-23 | — | — | US | disclosed |
| US-5658928-A | ANTICOAGULANTS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS,WOUND HEALING AGENTS, OSTEOPOROSIS | HOFFMANN-LA ROCHE INC. (US) | 1997-08-19 | — | — | US | disclosed |
| US-5545658-A | FOR TREATMENT OR PROPHYLAXIS OF ILLNESSES WHICH ARE CAUSED BY THE BINDING OF ADHESIVE PROTEINS TO BLOOD PLATELETS AND BY BLOOD PLATELET AGGREGATION AND CELL-CELL ADHESION | HOFFMAN-LA ROCHE INC. (US) | 1996-08-13 | — | — | US | disclosed |